Trial intelligence / Profile preview

Platelet Characterization in Atrial Fibrillation

NCT02817815Terminated

Sponsor
Centre Hospitalier Universitaire de Bordeaux
Start
Nov 2016
Primary completion
Oct 2018
Countries
1
01

Overview

Open-label trial (5 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoints: Maximal Platelet Aggregation Level at Day 1, Maximal Platelet Disaggregation Level at Day 1 and 4 more. Started Nov 2016; status: terminated.

Beyond the preview

Go deeper on NCT02817815.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02817815.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call